Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Exp Neurol. 2013 May 28;0:126–132. doi: 10.1016/j.expneurol.2013.05.014

Table 1.

Summary of the neuromodulators and potential therapeutic agents postulated to be involved in nigral neurotoxicity in vivo in animal models of PD from publications in 2012

Pro-inflammatory Anti-inflammatory Potential Therapeutic Agents
Angiotensin II/AT1 Receptor NRSF/REST Eicosapentanoic Acid
Substance P/NK-1 Receptor Dynorphin Napthazarin
Wnt/β-catenin Curcuminoids
PPAR-γ Atorvastatin
GDNF Simvastatin
Cyp2d22 Fucoidan
Tenuingenin